MULTAQ - dronedarone tablet, film coated 
Physicians Total Care, Inc.

----------

Medication Guide
MULTAQ (MUL-tak)
(dronedarone) Tablets

Read this Medication Guide before you start taking MULTAQ and each time you get a refill. There may be new information. This information does not take the place of talking with your doctor about your medical condition or your treatment.

What is the most important information I should know about MULTAQ?

1.
MULTAQ is not for people with heart failure with symptoms which recently worsened or for people with severe heart failure. People with these conditions who take MULTAQ have an increased chance of dying. Heart failure means your heart does not pump blood through your body as well as it should.

Do not take MULTAQ if you have symptoms of heart failure which recently worsened or if you have severe heart failure.

Call your doctor right away if you have any signs and symptoms of heart failure:

2.
MULTAQ is not for people with a type of atrial fibrillation (irregular heart rhythm) called permanent atrial fibrillation (AF). In permanent AF, your heartbeat stays in atrial fibrillation and will not or cannot be changed back to a normal rhythm. Your doctor will monitor your heart rhythm regularly to make sure your heartbeat keeps a normal rhythm.

Do not take MULTAQ if you have permanent AF.

Call your doctor right away if you notice that your pulse is irregular. This is a sign that you are in atrial fibrillation.

3.
MULTAQ may cause liver problems, including life-threatening liver failure. Your doctor may order blood tests to check your liver before you start taking MULTAQ and during treatment. In some cases MULTAQ treatment may need to be stopped. Tell your doctor right away if you develop any of these signs and symptoms of liver problems:
  • loss of appetite, nausea, vomiting
  • fever, feeling unwell, unusual tiredness
  • itching
  • yellowing of the skin or the whites of the eyes (jaundice)
  • unusual darkening of the urine
  • right upper stomach area pain or discomfort

What is MULTAQ?

MULTAQ is a prescription medicine used to lower the chance that you would need to go into the hospital for atrial fibrillation. It is meant for people who have had atrial fibrillation in the past but are now in normal rhythm.

It is not known if MULTAQ is safe and effective in children younger than age 18 years old.

Who should not take MULTAQ?

See "What is the most important information I should know about taking MULTAQ?"

Do not take MULTAQ if:

What should I tell my doctor before starting MULTAQ?

Be sure to tell your doctor and pharmacist if you take:

Some of these medicines could keep MULTAQ from working well or make it more likely for you to have side effects.

How should I take MULTAQ?

What should I avoid while taking MULTAQ?

Do not drink grapefruit juice while you take MULTAQ. Grapefruit juice can increase the amount of MULTAQ in your blood and increase the likelihood that you will have a side effect of MULTAQ.

What are the possible side effects of MULTAQ?

MULTAQ may cause serious side effects, including:

The most common side effects of MULTAQ include:

Tell your doctor about any side effect that bothers you or that does not go away. These are not all the possible side effects of MULTAQ. For more information ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store MULTAQ?

Store MULTAQ at room temperature (59–86°F or 15–30°C).

Keep MULTAQ and all medicines out of the reach of children.

General information about MULTAQ

Medicines are sometimes used for purposes not mentioned in a Medication Guide. Do not use MULTAQ for a condition for which it was not prescribed. Do not give MULTAQ to other people, even if they have the same symptoms or condition. It may harm them.

This Medication Guide summarizes the most important information about MULTAQ. If you would like more information:

What are the ingredients in MULTAQ?

Active ingredient: dronedarone

Inactive ingredients: hypromellose, starch, crospovidone, poloxamer 407, lactose monohydrate, colloidal silicon dioxide, magnesium stearate polyethylene glycol 6000, titanium dioxide, carnauba wax

This Medication Guide has been approved by the U.S. Food and Drug Administration.
Issued December 2011

Manufactured by Sanofi Winthrop Industrie
1, rue de la Vierge
33440 Ambares, France

©sanofi-aventis, 2011
All rights reserved.

MULTAQ is a trademark of sanofi-aventis.

The brands listed are the registered trademarks of their respective owners and are not trademarks of sanofi-aventis U.S. LLC.

sanofi-aventis U.S. LLC
Bridgewater, NJ 08807

Additional bar code label applied by:
Physicians Total Care, Inc.
Tulsa, Oklahoma       74146

Revised: 12/2011
Physicians Total Care, Inc.